Table 1.

Physiological and hemodynamic parameters

Group	Gestational Age	Fetal Heart Rate, beats/min	Mean UA Velocity, mm/s	Peak UA Velocity, mm/s	UA Blood Flow, ml/min
Control	E15.5	184 (CI: 170–198)*†	25 (CI: 20–30)	56 (CI: 47–65)	0.09 (CI: 0.07–0.11)†
cART	E15.5	215 (CI: 194–236)	24 (CI: 17–31)	52 (CI: 35–69)	0.07 (CI: 0.05–0.09)‡
Control	E17.5	211 (CI: 195–227)	26 (CI: 23–29)	57 (CI: 50–64)	0.12 (CI: 0.10–0.14)
cART	E17.5	232 (CI: 206–258)	38 (CI: 21–55)	78 (CI: 46–110)	0.15 (CI: 0.09–0.21)

Data are presented as means and 95% confidence interval (CI) values. cART, combination antiretroviral therapy; E15.5, embryonic day 15.5; E17.5, embryonic day 17.5; UA, umbilical artery.

^*P < 0.01 compared with cART-treated fetuses at E15.5;

^†P < 0.01 compared with control fetuses at E17.5;

^‡P < 0.01 compared with cART-treated fetuses at E17.5 (as determined by two-way ANOVA followed by a post hoc t-test).